Synthesis and biological evaluation of some 17-picolyl and 17-picolinylidene androst-5-ene derivatives

Steroids

Volumn 72, Issue 1, 2007, Pages 31-40

  Gaši, Katarina M Penov ^a   Brenesel, Maja Dj Djurendić ^a   Djurendić, Evgenija A ^a   Sakač, Marija N ^a   Čanadi, Janoš J ^a   Daljev, Jovana J ^a   Armbruster, Thomas ^b   Andrić, Silvana ^a   Sladić, Dušan M ^c   Božić, Tatjana T ^c   Novaković, Irena T ^d   Juranić, Zorica D ^e  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Androst 5 ene derivatives; Antibacterial activity; Antitumor activity; Aromatase inhibition; Picolyl and picolinylidene derivatives; X ray analysis

Indexed keywords

17 PICOLINYLIDENE ANDROST 4 ENE 3 ONE; 17 PICOLINYLIDENE ANDROST 4 ENE 3,16 DIONE; 17BETA HYDROXY 17ALPHA PICOLYL ANDROST 4 ENE 3 ONE; 17BETA HYDROXY 17ALPHA PICOLYL ANDROSTA 1,4,6 TRIENE 3 ONE; 2,3 DICHLORO 5,6 DICYANO 1,4 BENZOQUINONE; 3BETA HYDROXY 17 PICOLINYLIDENE ANDROST 5 ENE; 3BETA HYDROXY 17 PICOLINYLIDENE ANDROST 5 ENE 16 ONE; 3BETA,17BETA DIHYDROXY 17ALPHA PICOLYL ANDROST 5 ENE HYDROBROMIDE; ANDROSTANE DERIVATIVE; BENZOQUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; IC 50; MALE; MELANOMA; MYELOID LEUKEMIA; NONHUMAN; OPPENAUER OXIDATION; PERIPHERAL BLOOD MONONUCLEAR CELL; RAT; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA; X RAY ANALYSIS;

ANDROSTENES; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; AROMATASE; AROMATASE INHIBITORS; CELL LINE, TUMOR; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MELANOMA; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP;

ARTEMIA; ARTEMIA SALINA;

EID: 33846020540     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2006.10.002     Document Type: Article

References (33)

1. For recent reviews of aromatase inhibitors see:
2. Santen R.J. Inhibition of aromatase insights from recent studies. Steroids 68 (2003) 559-567
3. Johnston S.R.D., and Dowsett M. Aromatase inhibitors for breast cancer: lessons from the laboratory. Nature Rev Cancer 3 (2003) 821-831
4. Brueggemeier R.W., Hackett J.C., and Diaz-Cruz E.S. Aromatase inhibitors in the treatment of breast. Cancer Endocrin Rev 26 (2005) 331-345
5. Freedman O.C., Verma S., and Clemons M.J. Pre-menopausal breast cancer and aromatase inhibitors: treating a new generation of women. Breast Cancer Res Treat 99 (2006) 241-247
6. Bria E., Ciccarese M., Giannarelli D., et al. Early switch with aromatase inhibitors as adjuvant hormonal therapy for postmenopausal breast cancer: pooled-analysis of 8794 patients. Cancer Treat Rev 32 (2006) 325-332
7. Bonneterre J.B. Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Cancer 92 (2001) 2247-2258
8. Ellis Mj., Coop A., Singh B., Mauriac L., Llombert-Cussac A., and Janicke F. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol 19 (2001) 3808-3816
9. Paridaens R., Dirix L., Lohrisch C., et al. Promising activity and safety of exemestane as first-line hormonal therapy in metastatic breast cancer patients: final results of an EORTC randomised phase II trial. Breast Cancer Res Treat 64 (2000) 52
10. Goss P.E., and Strasser K. Aromatase inhibitors in the treatment and prevention of breast cancer. J Clin Oncol 19 (2001) 881-894
11. Houssami N., Cuzick J., and Dixon J.M. The prevention, detection, and management of breast cancer. MJA 184 (2006) 230-234
12. McCague R., and Rowlands M.G. Conformational Analysis of the Aromatase Inhibitor 3-Ethyl-3(4-pyridyl)piperidine-2.6-dione (Rogletimide) and Discovery of Potent 5-Alkyl Derivatives. J Med Chem 35 (1992) 3699-3704
13. Andrić S., Kostić T., Sakač M., Medić-Mijačević L.J., Penov Gaši K., and Kovačević R. Biological characterization of some novel 5-androstene derivatives as potential antiandrogens. Proceedings for Natural Sciences, vol. 94. Matica Srpska Novi Sad (1998) 43-51
14. Penov Gaši K., Stanković S., Csanadi J., D{combining short stroke overlay}urendić E., Sakač M., Medić-Mijačević L.J., Arcson O., Stojanović S., Andrić S., Molnar Gabor D., and Kovačević R. New D-Modified androstane derivatives as aromatase inhibitors. Steroids 66 (2001) 645-653
15. Penov Gaši K., Stojanović S., Sakač M., Popsavin M., Jovanović Šanta S., Stanković S., Klisurić O., Andrić N., and Kovačević R. Synthesis and anti-aromatase activity of some new steroidal D-lactones. Steroids 70 (2005) 47-53
16. Penov Gaši K., Miljković D., Medić-Mijačević L.J., {Eth}urendić E., Stojanović S., Sakač M., {Eth}urendić M., Stanković S., Lazar D., Andrić S., and Kovačević R. Synthesis, X-ray crystal structures and biological activity of 16-amino-17-substituted-D-homo steroid derivatives. Steroids 68 (2003) 667-676
17. Yamada K., Harada N., Honda S., and Takagi Y. Regulation of placenta-specific expression of the aromatase cytochrome P-450 gene. J Biol Chem 270 (1995) 25064-25069
18. Santen R.J., Santner S.J., Harvey H.A., Lipton A., Simmonds M., Feil P.D., Manders E., and Davis T.S. Marked heterogeneity of aromatase activity in human malignant melanoma tissue. Eur J Cancer Clin Oncol 24 (1988) 1811-1816
19. Fiorelli G., Frediani U., Martineti V., Franchi A., Gori F., Franceschelli F., Tanini A., Serio M., and Brandi M.L. Aromatase expression and activity in the human leukaemic cell line FLG 29.1. J Steroid Biochem Mol Biol 66 (1998) 105-112
20. Meyer B.N., Ferrigni N.R., Putnam J.E., Jacobsen L.B., Nichols D.E., and McLaughlin J.L. Brine shrimp: A convenient general bioassay for active plant constituents. Planta Med 45 (1982) 31-34
21. Swevers L., Lambert J.G.D., and DeLoof A. Metabolism of vertebrate-type steroids by tissues of three crustacean species. Comp Biochem Physiol 99B (1991) 35-41
22. Pettit R.K., Cage G.D., Pettit G.R., and Liebman J.A. Antimicrobial and cancer cell growth inhibitory activities of 3β-acetoxy-17β-(l-prolyl)amino-5α-androstane in vitro. Int J Antimicrob Agents 15 (2000) 299-304
23. Fieser L.F., and Fieser M. Steroids (1967), Reinhold Publishing Co., New York p. 512
24. Kovačević R., and Sarač M. Bromocriptine-induced inhibition of hydroxylase/lyase activity of adult rat Leydig cells. J Steroid Biochem Mol Biol 46 (1993) 841-845
25. Kovačević R., Vojinović-Miloradov M., Teodorović I., and Andrić S. Effect of PCBs on androgen production by suspension of adult rat Leydig cells in vitro. J Steroid Biochem Mol Biol 52 (1995) 595-597
26. Marić D., Kostić T., and Kovačević R. Effects of acute and chronic immobilization stress on rat Leydig cell steroidogenesis. J Steroid Biochem Mol Biol 58 (1996) 351-355
27. Ketchum P.A. Microbiology: concepts and applications (1988), John Wiley and Sons, New York p. 512-3
28. Clothier R.H. The FRAME cytotoxicity test. In: O'Hare S., and Atterwill C.K. (Eds). Methods in molecular biology vol. 43 (1995), Humana Press, Totowa, NJ 109-118
29. Ohno M., and Abe T. Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6). J Immunol Methods 145 (1991) 199-203
30. Miljković D., Gaši K., Kindjer M., Stanković S., and Ribar B. Partial syntheses of 21,27-bisnordemissidine from epiandrosterone and dehydroepiandrosterone acetates. Crystal and molecular structure of 21,27-bisnordemissidine hydrobromide. Croat Chem Acta 58 (1985) 721-736
31. Miljković D., and Gaši K. A novel synthetic approach to 3β-acetoxy-17-picolinylidene-5-androstene-16-one. Bull Soc Chim Beograd 47 (1982) 173-181
32. Miljković D., and Gaši K. 3β-Acetoxy-17-picolinylidene-5-androstene-16-one-the key intermediate in 21,27-bisnorsolanidine synthesis. Bull Soc Chim Beograd 46 (1981) 263-268
33. Medić Mijačević LJ, Miljković D, Sakač M, Gaši K. Study on catalytic hydrogenation of isomeric (Z)- and (E)-3β-acetoxy-17-picolinylidene-5-androstene-16-ones. Proceedings for Natural Sciences, Matica Srpska 1993;84:69-72.